Patents by Inventor Erik T. Dustrude

Erik T. Dustrude has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain
    Patent number: 10287334
    Abstract: Disclosed herein are isolated polypeptides capable of preventing collapsin response mediator protein 2 (CRMP2)-small ubiquitin-like modifier (SUMO)ylation mediated trafficking of voltage gated sodium channel 1.7 (Nav1.7) function. In some examples, the disclosed peptides comprise three to twenty amino acids and include the amino acid sequence KMD. Also disclosed are methods of decreasing nociception including administering an effective amount of one or more disclosed peptides to a subject in need thereof, such as a subject experiencing chronic pain.
    Type: Grant
    Filed: March 6, 2015
    Date of Patent: May 14, 2019
    Assignee: THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Rajesh Khanna, May Khanna, Todd W. Vanderah, Erik T. Dustrude
  • NON-NARCOTIC CRMP2 PEPTIDES TARGETING SODIUM CHANNELS FOR CHRONIC PAIN
    Publication number: 20170008939
    Abstract: Disclosed herein are isolated polypeptides capable of preventing collapsin response mediator protein 2 (CRMP2)-small ubiquitin-like modifier (SUMO)ylation mediated trafficking of voltage gated sodium channel 1.7 (Nav1.7) function. In some examples, the disclosed peptides comprise three to twenty amino acids and include the amino acid sequence KMD. Also disclosed are methods of decreasing nociception including administering an effective amount of one or more disclosed peptides to a subject in need thereof, such as a subject experiencing chronic pain.
    Type: Application
    Filed: March 6, 2015
    Publication date: January 12, 2017
    Inventors: Rajesh Khanna, May KHANNA, Todd W. Vanderah, Erik T. Dustrude